Frontage Announces the Appointment of Michael J. Potchoiba, M.S to Head the QWBA-Center of Excellence in Exton, PA.
Frontage Laboratories, Inc., is pleased to announce the appointment of Michael J. Potchoiba, M.S to head the QWBA-Center of Excellence in Exton, PA. Mr. Potchoiba joined Frontage Labs late March 2020 and will oversee the operation and growth of QWBA-Center of Excellence. Potch has over 28 years of experience in conducting QWBA studies and projecting dosimetry for human C14 clinical studies.
Prior to joining Frontage, Mr. Potchoiba was a Senior Study Director at Covance for 11 years where he directed radiolabeled ADME, QWBA, radio-analysis for human ADME clinical studies, dosimetry projections, PK screening, and metabolite characterization studies. Previously, he spent 18 years at Pfizer in the Department of Pharmacokinetics, Pharmacodynamics and Metabolism conducting radio labeled PK, QWBA and mass balance studies.
Mr. Potchoiba received his M.S. in Animal Science, Washington State University. He has over 40 publications in peer-reviewed journals and is the lead author of five WBAL-related manuscripts.